The development of an organism largely depends on the orchestration between cellular growth and the timing of developmental cell cycles, which is fine tuned by several genes. The transcript stability and abundance of these genes during development and throughout adulthood regulates animal form and function while mutation in them causes the cells to lose control over the timely progression of developmental cell cycles and may trigger tumorigenesis. mRNA decapping is a key step of mRNA degradation involving the removal of the 5'm7G cap of mRNAs. In Drosophila melanogaster, the mRNA decapping enzyme 2-DCP2, performs this step in association with other proteins. DCP2 has been studied extensively in various model organisms in the light of maintenance of transcript abundance and stability. In Drosophila melanogaster, loss-of-function alleles of DCP2, viz., DCP2BG01766 and DCP2e00034 cause absolute embryonic lethality in homozygotes, whereas another allele, DCP2l(3)tb causes larval brain tumors and absolute pupal lethality in the homozygotes. DCP2BG01766 and DCP2l(3)tb show defects in cuticular denticles and elevated expression of activated JNK in the cells of the lateral epidermis. Parallely, the DCP2BG01766 mutant embryos show accumulation of Rab11, a vesicular trafficking protein in the lateral epidermis as well as elevated expression of activated JNK in the cells of the neuro-ectoderm. The tumorous allele, DCP2l(3)tb exhibits hyperplastic nature, with increased number and size of cells without loss of epithelial polarity along with impaired fasciculation of axons, implying DCP2 to be an essential candidate for development of the nervous system in Drosophila. Taken together, our results shed light on hitherto undescribed roles of DCP2 during Drosophila development, besides its cognate function. Inherited muscular dystrophies are developmental disorders of muscle cells and tissues; understanding how muscle development is disrupted by disease mutations may contribute to developing treatments. An early stage of muscle development involves the differentiation of myoblasts by cell fusion into myotubes, where multiple nuclei are linearly and evenly spaced in a syncytium, in part by microtubule motor activity. During this process, multiple subcellular components are dramatically reorganized. In particular, the microtubule organizing centre (MTOC) relocalizes from the compact volume of the myoblast centrosome to become uniformly distributed on the myotube nuclear envelope surface. The function and molecular mechanism of MTOC relocation is unclear but coincides with increased expression of the nuclear envelope (NE) protein Nesprin-1. Upon siRNA depletion or CRISPR disruption of Nesprin-1 in C2C12 myotubes, and in congenital muscular dystrophy patient myotubes mutant for Nesprin-1, we found that microtubule nucleation from the NE is abrogated, representing loss of NE MTOC activity. Using proximity-dependent biotin identification (BioID) with Nesprin-1 as bait, we identified the centrosome proteins Pcnt, Akap450, and Pcm1 as potential Nesprin-1 interactors. Pcnt, Akap450 and Pcm1 all localized to the myotube NE in a Nesprin-1-dependent fashion. Intriguingly, Pcnt and Akap450 are scaffolds for the microtubule-nucleating gamma-tubulin complexes. However, only loss of Akap450, but not Pcnt or Pcm1, disrupted MT nucleation from the NE. Thus NE MTOC activity is mediated by Nesprin-1 recruitment of Akap450, which in turn recruits MT nucleation activity to the NE. We found that Nesprin-1 is required for proper nuclear positioning in C2C12 and human myotubes. Using computational modeling, we determined that Nesprin-1 recruitment of both MTOC and kinesin motor activity to the NE is required for this process. Thus disruption of microtubule nucleation and motor activity at the nuclear envelope may contribute to congenital muscular dystrophy by blocking appropriate nuclear migration in myotubes. Nuclear pore complexes (NPCs) are large protein complexes embedded in the nuclear envelope as a selective gate for nucleocytoplasmic trafficking of macromolecules. Additionally, NPCs also function as scaffolds that spatially confine certain biological Abstracts S63
Banaras Hindu University, Varanasi, India
The development of an organism largely depends on the orchestration between cellular growth and the timing of developmental cell cycles, which is fine tuned by several genes. The transcript stability and abundance of these genes during development and throughout adulthood regulates animal form and function while mutation in them causes the cells to lose control over the timely progression of developmental cell cycles and may trigger tumorigenesis. mRNA decapping is a key step of mRNA degradation involving the removal of the 5'm7G cap of mRNAs. In Drosophila melanogaster, the mRNA decapping enzyme 2-DCP2, performs this step in association with other proteins. DCP2 has been studied extensively in various model organisms in the light of maintenance of transcript abundance and stability. In Drosophila melanogaster, loss-of-function alleles of DCP2, viz., DCP2BG01766 and DCP2e00034 cause absolute embryonic lethality in homozygotes, whereas another allele, DCP2l(3)tb causes larval brain tumors and absolute pupal lethality in the homozygotes. DCP2BG01766 and DCP2l(3)tb show defects in cuticular denticles and elevated expression of activated JNK in the cells of the lateral epidermis. Parallely, the DCP2BG01766 mutant embryos show accumulation of Rab11, a vesicular trafficking protein in the lateral epidermis as well as elevated expression of activated JNK in the cells of the neuro-ectoderm. The tumorous allele, DCP2l(3)tb exhibits hyperplastic nature, with increased number and size of cells without loss of epithelial polarity along with impaired fasciculation of axons, implying DCP2 to be an essential candidate for development of the nervous system in Drosophila. Taken together, our results shed light on hitherto undescribed roles of DCP2 during Drosophila development, besides its cognate function. Inherited muscular dystrophies are developmental disorders of muscle cells and tissues; understanding how muscle development is disrupted by disease mutations may contribute to developing treatments. An early stage of muscle development involves the differentiation of myoblasts by cell fusion into myotubes, where multiple nuclei are linearly and evenly spaced in a syncytium, in part by microtubule motor activity. During this process, multiple subcellular components are dramatically reorganized. In particular, the microtubule organizing centre (MTOC) relocalizes from the compact volume of the myoblast centrosome to become uniformly distributed on the myotube nuclear envelope surface. The function and molecular mechanism of MTOC relocation is unclear but coincides with increased expression of the nuclear envelope (NE) protein Nesprin-1. Upon siRNA depletion or CRISPR disruption of Nesprin-1 in C2C12 myotubes, and in congenital muscular dystrophy patient myotubes mutant for Nesprin-1, we found that microtubule nucleation from the NE is abrogated, representing loss of NE MTOC activity. Using proximity-dependent biotin identification (BioID) with Nesprin-1 as bait, we identified the centrosome proteins Pcnt, Akap450, and Pcm1 as potential Nesprin-1 interactors. Pcnt, Akap450 and Pcm1 all localized to the myotube NE in a Nesprin-1-dependent fashion. Intriguingly, Pcnt and Akap450 are scaffolds for the microtubule-nucleating gamma-tubulin complexes. However, only loss of Akap450, but not Pcnt or Pcm1, disrupted MT nucleation from the NE. Thus NE MTOC activity is mediated by Nesprin-1 recruitment of Akap450, which in turn recruits MT nucleation activity to the NE. We found that Nesprin-1 is required for proper nuclear positioning in C2C12 and human myotubes. Using computational modeling, we determined that Nesprin-1 recruitment of both MTOC and kinesin motor activity to the NE is required for this process. Thus disruption of microtubule nucleation and motor activity at the nuclear envelope may contribute to congenital muscular dystrophy by blocking appropriate nuclear migration in myotubes. Nuclear pore complexes (NPCs) are large protein complexes embedded in the nuclear envelope as a selective gate for nucleocytoplasmic trafficking of macromolecules. Additionally, NPCs also function as scaffolds that spatially confine certain biological Abstracts S63
